Patent applications published 16 February 2011
Selected patent applications from the weekly European Patents Bulletin
- Benzene sulphonamide thiazole and oxazole compounds
GlaxoSmithKline 2282636*
- Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration
Schapira, Jay N; Makkar, Raj 2282718*
- Compsns and methods for treating multiple sclerosis
Revalesio 2282719*
- Intracellular antibody delivery
Biocompatibles UK 2282720*
- Transnasal anticonvulsive pharmaceutical compsn comprising poorly soluble anticonvulsant
SK Holdings 2282721*
- Self-microemulsifying systems incorporated into liquid core microcapsules
LEK Pharmaceuticals 2282722*
- Endoplasmic reticulum targeting liposomes
University of Oxford 2282723*
- Modified drugs for use in liposomal nanoparticles
The University of British Columbia 2282724*
- Nasal formulations of insulin
CPEX Pharmaceuticals 2282725*
- Delivery system for an active ingredient
Firmenich 2282726*
- Polymerised micelles
Les Laboratoires Servier; Commissariat a l ‘energie Atomique 2282727*
- Modulators of the VPS10P-domain receptors for the treatment of cardiovascular disease
H Lundbeck 2282728*
- Methods and compsns for treating inflammation and inflammation-related pathologies
Livionex 2282729*
- Methods of treating fungal infections
Northeastern University 2282730*
- Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel
Galderma Research & Development 2282731*
- Use of an olive oil extract to control skin ageing
Sprim 2282732*
- Protection of normal cells
Florida Atlantic University; The Hospital for Special Surgery 2282733*
- Method for protecting humans against superficial vasodilator flush syndrome
Theta Biological Consulting & Development 2282734*
- Compounds, compsns and methods of or making the same
Signum Biosciences 2282735*
- Tetrazole compounds for reducing citric acid
Wellstat Therapeutics 2282736*
- Compsns and methods for treating periodontal disease comprising clonidine, sulindac and/or fluoxinolone
Warsaw Orthopaedic 2282737*
- Promoting axon regeneration in the adult CNS through control of protein translation
Children’s Medical Center Corp 2282738*
- Sequential administration of chemo-therapeutic agents for treatment of cancer
Schering 2282739*
- Antifolate compsns
Chelsea Therapeutics 2282740*
- Treating eosinophilic esophagitis
Meritage Pharma 2282741*
- Inhibitors of fatty acid amide hydrolase
Infinity Pharmaceuticals 2282742*
- Sulphated unsaturated disaccharide chondroitin sulphate in connective tissue protection and repair
Nestec 2282743*
- Oligomeric compounds comprising tricyclic nucleosides and methods for their use
Isis Pharmaceuticals 2282744*
- Composite enterocystoplasty
Advanced Technologies and Regenerative Medicine 2282745*
- Compsns and methods using stem cells in cutaneous wound healing
Neostem 2282746*
- Use of enteric glia
Neurological Technologies 2282747*
- Treatment of brain damage using umbilical cord blood cells
Stemcyte 2282748*
- Anti-adhesion barrier wound dressing comprising processed amniotic tissue and method of use
Allosource 2282749*
- Extract with high amount of bioactive compounds and its use
Aromtech 2282750*
- Compartment-specific plant extract combination of Gingko biloba extract and ginseng extract having a tandem effect
Merz Pharma 2282751*
- Saponin extract from Saponaria spp and uses thereof
National Research Council of Canada; University of Saskatchewan 2282752*
- Assay for pathogenic conformers
Novartis 2282753*
- Method of treating peripheral arterial disease
Orthologic; Texas A&M University System 2282754*
- Inhibition of angiogenesis
Transmolecular 2282755*
- Methods of diagnosing, preventing and treating bone mass diseases
The Trustees of Columbia University in the City of New York 2282756*
- Neutralisation of GM-CSF for the treatment of heart failure
Kalobios Pharmaceuticals 2282757*
- Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders
BioArtic Neuroscience 2282758*
- Use of nucleic acids with reduced pressure therapy for treating wounds
KCI Licensing 2282759*
- Method for the treatment or prophylaxis of chronic inflammatory diseases
Drug Discovery Factory 2282760*
- Inhibition of scarring using TGF-beta 3
Renovo 2282761*
- Novel macrocyclic inhibitors of hepatitis C virus replication
Intermune 2282762*
- Compsns useful in the treatment of diabetes and other chronic disorders
National Institute of Immunology; Indian Institute of Science 2282763*